Qubit Pharmaceuticals

Qubit Pharmaceuticals is a pioneering deep-tech company specializing in the discovery and design of novel drug candidates for complex targets, by leveraging cutting-edge molecular simulation technologies, hybrid High-Performance Computing (HPC), and Artificial Intelligence (AI). Qubit Pharmaceuticals stands at the forefront of innovation in pharmaceutical research with their groundbreaking research in quantum computing applied to quantum chemistry that promises to revolutionize drug discovery, offering unprecedented precision and speed into identifying targets, discovering novel molecules and predicting their interactions. Qubit Pharmaceuticals leverages their technologies and expertise to advance 6 fully owned drug discovery programs focusing on cancer resistance and escapement, a growing concern in aging populations, and chronic inflammatory diseases. They also co-develop programs with academia and pharmaceutical partners.